Who can see your ADHD diagnosis and prescriptions in New Jersey

Worry about who will find out keeps some adults from getting evaluated for ADHD, especially because the usual medications are controlled substances tracked by the state. In New Jersey, several layers of law protect psychiatric records: federal HIPAA rules, the Board of Medical Examiners' records regulation, a court privilege for mental health care, and a confidential prescription monitoring program. Each has limits. This page sets them out as of October 2026. It is general information, not legal advice. For a specific concern, ask your clinician's office for its notice of privacy practices or speak with a health care attorney.

Who can see what: a summary

HIPAA: the federal baseline

Under 45 CFR 164.508, a covered health care provider generally may not use or disclose your protected health information without a valid written authorization, except as the regulations allow. Section 164.506 allows use and disclosure for treatment, payment and health care operations. That is why your pharmacy and insurer receive information without a new form each time.

HIPAA governs providers and health plans, not employers. The federal Department of Health and Human Services says the Privacy Rule does not apply to employers' actions in most cases, and that a provider cannot give your employer your information without your authorization unless other laws require it.

HIPAA's stricter protection for "psychotherapy notes" is narrower than many people think. The definition in 45 CFR 164.501 excludes medication prescription and monitoring, test results, and any summary of diagnosis, symptoms, treatment plan and progress. For an adult with ADHD, the diagnosis, the stimulant prescription and medication follow-up notes are ordinary protected health information. They are confidential under the general rule, without the extra psychotherapy-note layer. Your right to inspect and copy your record under 45 CFR 164.524 has an exception for psychotherapy notes.

New Jersey's physician records rule

For physicians and other licensees of the Board of Medical Examiners, N.J.A.C. 13:35-6.5 sets the state rules on records. It applies to a private psychiatric practice.

Your right to a copy

• The licensee must provide a copy of your treatment record or billing records no later than 30 days after your request, and may require the request in writing.
• Copy fees are capped at $1.00 per page or $100.00 for the entire record, whichever is less. For a record under 10 pages, up to $10.00 may be charged for postage and retrieval.
• The licensee may give a summary instead of a copy, at no more than the cost of the copy.
• If the licensee believes the subjective information would harm your mental or physical condition, the record must still be provided on request to your attorney, another licensed health care professional, your insurer, or a government reimbursement program.
• A record cannot be withheld over an unpaid balance if another health care professional needs it to treat you.
• Treatment records must be kept for seven years from the most recent entry.

When a record can be released without your request

The same rule requires confidentiality, with listed exceptions:

• a subpoena or demand from the Board of Medical Examiners or the Attorney General;
• reporting required by law, such as suspected child abuse;
• sharing pertinent information with another licensed health care professional who is treating or consulting on your care, in your best interest;
• release to law enforcement or another clinician when the licensee has a good-faith belief that a patient may pose an imminent danger to self or others.

When you ask for records to go to a specific person or organization, the licensee must keep your current written authorization and send only what you requested. Moving records to a new psychiatrist is covered in switching ADHD psychiatrists in New Jersey.

A separate statute, N.J.S.A. 30:4-24.3, makes records of people served in noncorrectional institutions under Title 30 confidential, with exceptions such as patient consent or a court order. It is aimed at that system of facilities rather than a private office.

Privilege: what a court can make your psychiatrist say

New Jersey Rule of Evidence 534, effective July 1, 2016, created a single mental health service provider privilege. It covers psychiatrists, psychologists and other listed professionals. A patient may refuse to disclose, and may stop others from disclosing, confidential communications with the provider in a proceeding, and the provider must claim the privilege unless the patient says otherwise.

The rule lists exceptions. There is no privilege for communications relevant to:

• a proceeding in which your condition is an element of your own claim or defense;
• commitment or competence proceedings;
• a court-ordered examination, for the purpose ordered;
• mental health services sought to help commit a crime or fraud;
• an application to buy, own or carry a firearm, or the return of a firearm.

A court may also compel disclosure if you waived the privilege or if the privilege would violate a constitutional right. These rules govern court proceedings. They do not let anyone else request your chart.

The prescription monitoring program

Stimulants are Schedule II controlled substances, and New Jersey pharmacies report controlled dangerous substance prescriptions to the NJPMP. Under N.J.S.A. 45:1-46, that information "shall be confidential" and is not subject to public disclosure under the state open records law.

Beyond prescribers and pharmacists, the statute lists who may receive it:

• authorized Division of Consumer Affairs staff and contractors;
• a medical examiner investigating a death;
• other states' monitoring programs under an interoperability agreement;
• licensing board representatives in a bona fide investigation of a specific practitioner or pharmacist;
• law enforcement officers acting under a court order who certify a bona fide, specific investigation of a practitioner, pharmacist or patient;
• a Medicaid or similar program representative in a bona fide investigation;
• a grand jury under a properly issued subpoena;
• a mental health practitioner treating substance use disorder, with the patient's written consent.

Employers and private insurers are not on that list. A current patient may ask the prescriber for his or her own NJPMP information. How prescribers use the program is covered in the New Jersey Prescription Monitoring Program and ADHD medication.

Limits on confidentiality

• Duty to warn and protect. Under N.J.S.A. 2A:62A-16, a duty arises when a patient communicates a threat of imminent, serious physical violence against a readily identifiable person or against himself, and a reasonable professional would believe the patient intends to carry it out, or when circumstances would lead a reasonable professional to believe that. The duty can be met by steps such as arranging hospitalization, notifying police, or warning the intended victim. The statute also has a firearms notification provision. A diagnosis of ADHD does not trigger any of this.
• Reports about other clinicians. New Jersey's duty to report an impaired health professional does not apply when the knowledge came from treating that professional (N.J.S.A. 45:1-37(e)). See ADHD and professional licenses in New Jersey.
• Insurance claims. If you use insurance, the plan receives the claim. That is a permitted payment disclosure, separate from the NJPMP.
• Forms you sign. Job, license and clearance applications can include broad releases. Read them before signing.

If you are in crisis, call or text 988. Statewide crisis options are listed in mental health crisis resources in New Jersey.

Your employer

In practice, an employer learns of an ADHD diagnosis when you tell it or sign a release. Whether and how to do that is a separate decision, covered in telling your employer about ADHD in New Jersey. The New York rules, for commuters, are in who can see your ADHD diagnosis in New York. How an evaluation is conducted and recorded is described on the adult ADHD evaluation page.